CDEK by Data4ThePeople
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
← All indications

Appendiceal Neoplasms

Tumors or cancer of the APPENDIX.

Drugs by status

Phase 2 trials (14)

  • procaine benzylpenicillin
  • durvalumab
  • paclitaxel
  • nintedanib
  • mitomycin
  • leucovorin
  • oncos-102
  • cetuximab
  • clarithromycin
  • melphalan
  • floxuridine
  • nilotinib
  • cbx-12
  • jab-21822

Phase 1 trials (8)

  • irinotecan
  • doxorubicin
  • fluorouracil
  • sodium thiosulfate
  • oxaliplatin
  • cisplatin
  • vmd-928
  • lsta1

Other trials (7)

  • [18f]f-resca-rb14
  • [18f]f-resca-t4
  • [68ga]ga-dota-h2d3
  • [68ga]ga-nota-t4
  • [68ga]ga-nota-g5
  • [68ga]ga-nota-rnd20
  • [68ga]ga-nota-wwh347

Organizations

Organization Involved with Phase 2 Indications (16)

  • MedImmune
  • Targovax ASA
  • Boehringer Ingelheim
  • University of Pennsylvania
  • University of Pittsburgh
  • Cornell University
  • Harvard University
  • Ludwig Institute for Cancer Research
  • Mercy Medical Center
  • University of Florida
  • University of Kansas
  • University of Miami
  • University of Rochester
  • Uniformed Services University of Health Sciences
  • Washington University in St. Louis
  • Cancer Research Institute

Organization Involved with Phase 1 Indications (2)

  • University of Utah
  • University of Massachusetts

ICD-10 crosswalk

  • C18.1 — Malignant neoplasm of appendix

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.